CanSORT investigators are interested in various dimensions of cancer quality of care in diverse populations. We study topics such as appropriate use of treatments; patient perspectives about treatment decision-making and care; the quality of diagnostic tests; and quality of life during treatment and in the survivorship period.
A major focus of CanSORT research is on disparities in these outcomes across vulnerable populations defined by race, ethnicity, and sociodemographics. CanSORT research also focuses on provider and system level factors that influence patient outcomes such as use of interdisciplinary treatment decision models.
CanSORT research has advanced population-based cancer quality of care and outcomes research methods through an extremely productive collaboration between investigators and the NIH Surveillance, Epidemiology and End Results (SEER) registries located in the metropolitan areas of Los Angeles, Detroit, and the state of Georgia.
CanSORT also develops and evaluates interventions to improve cancer care including decision tools for patients and clinicians and dissemination strategies to more quickly move research results to the provider community.
CanSORT’s research portfolio of federally and internally funded research is over $15M. Our major sponsors include the National Cancer Institute, the American Cancer Society, and the University of Michigan Rogel Cancer Center.